Logo image of HLNE

HAMILTON LANE INC-CLASS A (HLNE) Stock Fundamental Analysis

USA - NASDAQ:HLNE - US4074971064 - Common Stock

131.04 USD
+3.19 (+2.5%)
Last: 11/7/2025, 8:00:02 PM
131.04 USD
0 (0%)
After Hours: 11/7/2025, 8:00:02 PM
Fundamental Rating

6

Overall HLNE gets a fundamental rating of 6 out of 10. We evaluated HLNE against 237 industry peers in the Capital Markets industry. While HLNE has a great profitability rating, there are some minor concerns on its financial health. HLNE shows excellent growth, but is valued quite expensive already. These ratings could make HLNE a good candidate for growth investing.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

HLNE had positive earnings in the past year.
In the past year HLNE had a positive cash flow from operations.
HLNE had positive earnings in each of the past 5 years.
Each year in the past 5 years HLNE had a positive operating cash flow.
HLNE Yearly Net Income VS EBIT VS OCF VS FCFHLNE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

1.2 Ratios

HLNE has a Return On Assets of 11.78%. This is amongst the best in the industry. HLNE outperforms 92.41% of its industry peers.
HLNE has a Return On Equity of 27.96%. This is amongst the best in the industry. HLNE outperforms 94.51% of its industry peers.
The Return On Invested Capital of HLNE (18.59%) is better than 95.36% of its industry peers.
The Average Return On Invested Capital over the past 3 years for HLNE is significantly above the industry average of 7.63%.
Industry RankSector Rank
ROA 11.78%
ROE 27.96%
ROIC 18.59%
ROA(3y)11.28%
ROA(5y)10.68%
ROE(3y)28.1%
ROE(5y)33.18%
ROIC(3y)22.58%
ROIC(5y)19.69%
HLNE Yearly ROA, ROE, ROICHLNE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80 100

1.3 Margins

HLNE's Profit Margin of 30.66% is fine compared to the rest of the industry. HLNE outperforms 76.37% of its industry peers.
HLNE's Profit Margin has improved in the last couple of years.
With a decent Operating Margin value of 43.91%, HLNE is doing good in the industry, outperforming 78.06% of the companies in the same industry.
In the last couple of years the Operating Margin of HLNE has remained more or less at the same level.
Industry RankSector Rank
OM 43.91%
PM (TTM) 30.66%
GM N/A
OM growth 3Y-1.19%
OM growth 5Y0.87%
PM growth 3Y-8.59%
PM growth 5Y6.57%
GM growth 3YN/A
GM growth 5YN/A
HLNE Yearly Profit, Operating, Gross MarginsHLNE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

6

2. Health

2.1 Basic Checks

HLNE has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, HLNE has more shares outstanding
HLNE has a worse debt/assets ratio than last year.
HLNE Yearly Shares OutstandingHLNE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
HLNE Yearly Total Debt VS Total AssetsHLNE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.2 Solvency

An Altman-Z score of 5.57 indicates that HLNE is not in any danger for bankruptcy at the moment.
The Altman-Z score of HLNE (5.57) is better than 86.50% of its industry peers.
HLNE has a debt to FCF ratio of 0.85. This is a very positive value and a sign of high solvency as it would only need 0.85 years to pay back of all of its debts.
HLNE has a better Debt to FCF ratio (0.85) than 90.72% of its industry peers.
A Debt/Equity ratio of 0.38 indicates that HLNE is not too dependend on debt financing.
The Debt to Equity ratio of HLNE (0.38) is better than 67.93% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF 0.85
Altman-Z 5.57
ROIC/WACCN/A
WACCN/A
HLNE Yearly LT Debt VS Equity VS FCFHLNE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

2.3 Liquidity

HLNE has a Current Ratio of 1.16. This is a normal value and indicates that HLNE is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.16, HLNE perfoms like the industry average, outperforming 54.01% of the companies in the same industry.
HLNE has a Quick Ratio of 1.16. This is a normal value and indicates that HLNE is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.16, HLNE is in line with its industry, outperforming 54.85% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.16
Quick Ratio 1.16
HLNE Yearly Current Assets VS Current LiabilitesHLNE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

8

3. Growth

3.1 Past

HLNE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 13.70%, which is quite good.
The Earnings Per Share has been growing by 20.18% on average over the past years. This is a very strong growth
Looking at the last year, HLNE shows a very strong growth in Revenue. The Revenue has grown by 28.73%.
The Revenue has been growing by 21.08% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)13.7%
EPS 3Y4.79%
EPS 5Y20.18%
EPS Q2Q%43.93%
Revenue 1Y (TTM)28.73%
Revenue growth 3Y24.67%
Revenue growth 5Y21.08%
Sales Q2Q%27.25%

3.2 Future

The Earnings Per Share is expected to grow by 13.89% on average over the next years. This is quite good.
The Revenue is expected to grow by 14.66% on average over the next years. This is quite good.
EPS Next Y0.58%
EPS Next 2Y10.36%
EPS Next 3Y13.89%
EPS Next 5YN/A
Revenue Next Year6.35%
Revenue Next 2Y12.62%
Revenue Next 3Y14.66%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
HLNE Yearly Revenue VS EstimatesHLNE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M 1B
HLNE Yearly EPS VS EstimatesHLNE Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 24.68, the valuation of HLNE can be described as rather expensive.
HLNE's Price/Earnings ratio is a bit more expensive when compared to the industry. HLNE is more expensive than 65.82% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.06. HLNE is around the same levels.
The Price/Forward Earnings ratio is 21.35, which indicates a rather expensive current valuation of HLNE.
HLNE's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. HLNE is more expensive than 60.76% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 32.73, HLNE is valued a bit cheaper.
Industry RankSector Rank
PE 24.68
Fwd PE 21.35
HLNE Price Earnings VS Forward Price EarningsHLNE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

67.93% of the companies in the same industry are more expensive than HLNE, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of HLNE is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 21.6
EV/EBITDA 23.21
HLNE Per share dataHLNE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates HLNE does not grow enough to justify the current Price/Earnings ratio.
HLNE has a very decent profitability rating, which may justify a higher PE ratio.
HLNE's earnings are expected to grow with 13.89% in the coming years. This may justify a more expensive valuation.
PEG (NY)42.31
PEG (5Y)1.22
EPS Next 2Y10.36%
EPS Next 3Y13.89%

4

5. Dividend

5.1 Amount

HLNE has a Yearly Dividend Yield of 1.69%.
Compared to an average industry Dividend Yield of 8.49, HLNE is paying slightly less dividend.
HLNE's Dividend Yield is slightly below the S&P500 average, which is at 2.37.
Industry RankSector Rank
Dividend Yield 1.69%

5.2 History

The dividend of HLNE is nicely growing with an annual growth rate of 19.56%!
HLNE has been paying a dividend for over 5 years, so it has already some track record.
HLNE has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)19.56%
Div Incr Years7
Div Non Decr Years7
HLNE Yearly Dividends per shareHLNE Yearly Dividends per shareYearly Dividends per share 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

37.04% of the earnings are spent on dividend by HLNE. This is a low number and sustainable payout ratio.
HLNE's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP37.04%
EPS Next 2Y10.36%
EPS Next 3Y13.89%
HLNE Yearly Income VS Free CF VS DividendHLNE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
HLNE Dividend Payout.HLNE Dividend Payout, showing the Payout Ratio.HLNE Dividend Payout.PayoutRetained Earnings

HAMILTON LANE INC-CLASS A

NASDAQ:HLNE (11/7/2025, 8:00:02 PM)

After market: 131.04 0 (0%)

131.04

+3.19 (+2.5%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)11-04 2025-11-04/amc
Earnings (Next)02-02 2026-02-02/bmo
Inst Owners96.85%
Inst Owner Change-1.92%
Ins Owners7.22%
Ins Owner Change-2.89%
Market Cap7.30B
Revenue(TTM)712.96M
Net Income(TTM)212.20M
Analysts76.92
Price Target163.71 (24.93%)
Short Float %5.96%
Short Ratio5.33
Dividend
Industry RankSector Rank
Dividend Yield 1.69%
Yearly Dividend1.38
Dividend Growth(5Y)19.56%
DP37.04%
Div Incr Years7
Div Non Decr Years7
Ex-Date12-19 2025-12-19 (0.54)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.26%
Min EPS beat(2)1.1%
Max EPS beat(2)27.41%
EPS beat(4)3
Avg EPS beat(4)9.11%
Min EPS beat(4)-3.63%
Max EPS beat(4)27.41%
EPS beat(8)5
Avg EPS beat(8)9.21%
EPS beat(12)8
Avg EPS beat(12)10.1%
EPS beat(16)12
Avg EPS beat(16)13.17%
Revenue beat(2)2
Avg Revenue beat(2)7.35%
Min Revenue beat(2)1.01%
Max Revenue beat(2)13.69%
Revenue beat(4)3
Avg Revenue beat(4)3.94%
Min Revenue beat(4)-3.38%
Max Revenue beat(4)13.69%
Revenue beat(8)5
Avg Revenue beat(8)7.81%
Revenue beat(12)7
Avg Revenue beat(12)8.52%
Revenue beat(16)9
Avg Revenue beat(16)8.28%
PT rev (1m)-2.96%
PT rev (3m)0.82%
EPS NQ rev (1m)-2.72%
EPS NQ rev (3m)0.89%
EPS NY rev (1m)1.08%
EPS NY rev (3m)11.04%
Revenue NQ rev (1m)0.5%
Revenue NQ rev (3m)5.71%
Revenue NY rev (1m)-1.04%
Revenue NY rev (3m)3.5%
Valuation
Industry RankSector Rank
PE 24.68
Fwd PE 21.35
P/S 10.55
P/FCF 21.6
P/OCF 20.86
P/B 9.62
P/tB 9.62
EV/EBITDA 23.21
EPS(TTM)5.31
EY4.05%
EPS(NY)6.14
Fwd EY4.68%
FCF(TTM)6.07
FCFY4.63%
OCF(TTM)6.28
OCFY4.79%
SpS12.42
BVpS13.62
TBVpS13.62
PEG (NY)42.31
PEG (5Y)1.22
Graham Number40.34
Profitability
Industry RankSector Rank
ROA 11.78%
ROE 27.96%
ROCE 22.22%
ROIC 18.59%
ROICexc 24.17%
ROICexgc 24.88%
OM 43.91%
PM (TTM) 30.66%
GM N/A
FCFM 48.83%
ROA(3y)11.28%
ROA(5y)10.68%
ROE(3y)28.1%
ROE(5y)33.18%
ROIC(3y)22.58%
ROIC(5y)19.69%
ROICexc(3y)26.87%
ROICexc(5y)22.9%
ROICexgc(3y)28.19%
ROICexgc(5y)23.88%
ROCE(3y)26.99%
ROCE(5y)23.55%
ROICexgc growth 3Y19.01%
ROICexgc growth 5Y-5.25%
ROICexc growth 3Y19.07%
ROICexc growth 5Y-4.68%
OM growth 3Y-1.19%
OM growth 5Y0.87%
PM growth 3Y-8.59%
PM growth 5Y6.57%
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF 0.85
Debt/EBITDA 0.92
Cap/Depr 126.25%
Cap/Sales 1.73%
Interest Coverage 250
Cash Conversion 111.67%
Profit Quality 159.29%
Current Ratio 1.16
Quick Ratio 1.16
Altman-Z 5.57
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)109.9%
Cap/Depr(5y)192.46%
Cap/Sales(3y)1.53%
Cap/Sales(5y)2.53%
Profit Quality(3y)135.75%
Profit Quality(5y)139.47%
High Growth Momentum
Growth
EPS 1Y (TTM)13.7%
EPS 3Y4.79%
EPS 5Y20.18%
EPS Q2Q%43.93%
EPS Next Y0.58%
EPS Next 2Y10.36%
EPS Next 3Y13.89%
EPS Next 5YN/A
Revenue 1Y (TTM)28.73%
Revenue growth 3Y24.67%
Revenue growth 5Y21.08%
Sales Q2Q%27.25%
Revenue Next Year6.35%
Revenue Next 2Y12.62%
Revenue Next 3Y14.66%
Revenue Next 5YN/A
EBIT growth 1Y8.35%
EBIT growth 3Y23.2%
EBIT growth 5Y22.13%
EBIT Next Year7.75%
EBIT Next 3Y14%
EBIT Next 5YN/A
FCF growth 1Y55.62%
FCF growth 3Y21.48%
FCF growth 5Y21.24%
OCF growth 1Y56.53%
OCF growth 3Y21.07%
OCF growth 5Y20.91%

HAMILTON LANE INC-CLASS A / HLNE FAQ

Can you provide the ChartMill fundamental rating for HAMILTON LANE INC-CLASS A?

ChartMill assigns a fundamental rating of 6 / 10 to HLNE.


What is the valuation status of HAMILTON LANE INC-CLASS A (HLNE) stock?

ChartMill assigns a valuation rating of 3 / 10 to HAMILTON LANE INC-CLASS A (HLNE). This can be considered as Overvalued.


Can you provide the profitability details for HAMILTON LANE INC-CLASS A?

HAMILTON LANE INC-CLASS A (HLNE) has a profitability rating of 7 / 10.


What are the PE and PB ratios of HAMILTON LANE INC-CLASS A (HLNE) stock?

The Price/Earnings (PE) ratio for HAMILTON LANE INC-CLASS A (HLNE) is 24.68 and the Price/Book (PB) ratio is 9.62.


How sustainable is the dividend of HAMILTON LANE INC-CLASS A (HLNE) stock?

The dividend rating of HAMILTON LANE INC-CLASS A (HLNE) is 4 / 10 and the dividend payout ratio is 37.04%.